High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study.
Raeseok LeeSung-Yeon ChoDong-Gun LeeDukhee NhoPublished in: Journal of Korean medical science (2024)
Among severe to critically ill patients with COVID-19, high-dose corticosteroid use was associated with increased 28-day all-cause mortality and showed a trend toward the development of CAPA.